2A Biosciences
Founded 2023 · 10 employees on LinkedIn · 1 known investors
2A Biosciences is a stealth-stage biotech developing precision 5-HT2A receptor agonists that activate the body's intrinsic regenerative pathways for nerve regeneration and reduced inflammation. Its platform originates in ophthalmology and is intended to expand into central nervous system and neurodegenerative diseases, and the company is preparing to begin clinical studies.
Investors · 1
In the news
Frequently asked questions
- What does 2A Biosciences do?
- 2A Biosciences is a stealth-stage biotech developing precision 5-HT2A receptor agonists that activate the body's intrinsic regenerative pathways for nerve regeneration and reduced inflammation. Its platform originates in ophthalmology and is intended to expand into central nervous system and neurodegenerative diseases, and the company is preparing to begin clinical studies.
- Who are 2A Biosciences's investors?
- 2A Biosciences's investors include LIONHEART VENTURES.